Related references
Note: Only part of the references are listed.Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry
Michele Iudici et al.
RHEUMATOLOGY (2022)
French Vasculitis Study Group recommendations for the management of COVID-19 vaccination and prophylaxis in patients with systemic vasculitis
Xavier Puechsl et al.
PRESSE MEDICALE (2022)
Sustained Remission of Granulomatosis With Polyangiitis After Discontinuation of Glucocorticoids and Immunosuppressant Therapy: Data From the French Vasculitis Study Group Registry
Xavier Puechal et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Avacopan for the Treatment of ANCA-Associated Vasculitis
David R. W. Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry
Michele Iudici et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Michael Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type
Zachary S. Wallace et al.
RHEUMATOLOGY (2020)
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
Pierre Charles et al.
ANNALS OF INTERNAL MEDICINE (2020)
Treatment of systemic necrotizing vasculitides: The 40-year experience of the French Vasculitis Study Group
Loic Guillevin
PRESSE MEDICALE (2020)
ANCA-associated vasculitis
A. Richard Kitching et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China
Dong-Yuan Chang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification
Samuel Deshayes et al.
RHEUMATOLOGY (2019)
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
M. Yates et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients
Divi Cornec et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center
Jan H. Schirmer et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Xavier Puechal et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Classifying Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides According to ANCA Type or Phenotypic Diagnosis: Salt or Pepper?
Christian Pagnoux et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's) Distinct Patient Subsets
Eli M. Miloslavsky et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan
Nobuyuki Ono et al.
RHEUMATOLOGY INTERNATIONAL (2015)
A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis Versus Myeloperoxidase ANCA-associated Nephritis
Aladdin J. Mohammad et al.
JOURNAL OF RHEUMATOLOGY (2014)
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis
Alfred Mahr et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis
Anoek A. E. de Joode et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis
Sophia Lionaki et al.
ARTHRITIS AND RHEUMATISM (2012)
Genetically Distinct Subsets within ANCA-Associated Vasculitis
Paul A. Lyons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Long-term patient survival in ANCA-associated vasculitis
Oliver Flossmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis
Randi Y. Leavitt et al.
ARTHRITIS AND RHEUMATISM (2010)
Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Bernhard Hellmich et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
Richard Watts et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Predictors of relapse and treatment resistance in antineutrophil cytoplasmic anti body-associated small-vessel vasculitis
SL Hogan et al.
ANNALS OF INTERNAL MEDICINE (2005)
Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies
M Chen et al.
KIDNEY INTERNATIONAL (2005)
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
D Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study
AD Booth et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)